// App-Quantinova.ai

4568 : Phase I trial of ASG-5ME in metastatic castration-resistant prostate cancer (CRPC).

Researchers

Presenter

  • Michael J. Morris

Principal Investigators

  • Justine Yang Bruce

  • Leonard M. Reyno

  • Banmeet Anand

  • Alan Hartford

  • Kathy Jelaca-Maxwell

  • Jacqueline Lackey

  • Mario A. Eisenberger

Medical Centers

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, James Buchanan Brady Urological Institute, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • ASG-5ME

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved